Emmaus Life Sciences, Inc. financial statements
Emmaus Life Sciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 12.45M | 10-K |
| Net income | −USD 7.49M | 10-K |
| Cash and equivalents | USD 2.13M | 10-Q |
| Total debt | USD 27.13M | 10-K |
Emmaus Life Sciences, Inc. financials on 6ix · Emmaus Life Sciences, Inc. on 6ix